Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms

Journal of Commercial Biotechnology

Volumn 16, Issue 1, 2010, Pages 17-32

  Ahn, Mark J ^a   Meeks, Michael ^b   Davenport, Sally ^a   Bednarek, Rebecca ^c  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b SAN FRANCISCO STATE UNIVERSITY   (United States)

^c Victoria University ^*

Author keywords

Agglomeration; Alliances; Biotechnology; Clusters

Indexed keywords

ABSOLUTE NUMBER; ABSOLUTE PERFORMANCE; ALLIANCES; BIOPHARMACEUTICAL INDUSTRY; BIOTECHNOLOGY CLUSTERS; BIOTECHNOLOGY FIRMS; EMPIRICAL ANALYSIS; FIRM PERFORMANCE; GEOGRAPHIC PROXIMITY; MARKET LEADER; SMALL BIOTECHNOLOGY COMPANIES;

AGGLOMERATION; INNOVATION; PROFITABILITY;

BIOTECHNOLOGY;

BIOTECHNOLOGICAL PRODUCTION; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG RESEARCH; EMPIRICAL RESEARCH; FINANCE; HEALTH CARE POLICY; LEADERSHIP; ORGANIZATIONAL EFFICIENCY; ORGANIZATIONAL STRUCTURE; PHARMACOECONOMICS; PROFIT; REVIEW; STRATEGIC PLANNING; TREND STUDY;

EID: 77749286722     PISSN: 14628732     EISSN: 1478565X     Source Type: Journal    
DOI: 10.1057/jcb.2009.8     Document Type: Review

References (78)

1. McGuire, J. L. and Hasskare, H. (2007) Pharmaceuticals, General Survey. Ullmann's Encyclopedia of Chemical Technology. Weinheim, Germany: Wiley-VCH.
2. Hadzovic, S. (1997) Pharmacy and the great contribution of Arab-Islamic science to its development. Medicinski Arhiv 51 (1-2): 47-50.
3. Roth, G. (2007) 2007 Top 20 pharmaceutical companies report. www.contractpharma.com, accessed 23 March 2008.
4. Capser, S. and Matreves, O. (2003) Institutional frameworks and innovation in the German and UK pharmaceutical industry. Research Policy 32 (10): 1865-1879.
5. BIO (Biotechnology Industry Organization). (2006) BIO 2005-2006: Guide to Biotechnology. Washington DC: BIO.
6. Goetz, S. and Morgan, S. (1995) State-level localization determinants of biotechnology firms. Economic Development Quarterly 9: 174-184.
7. Datamonitor. (2007) Global Pharmaceuticals: Industry Profile. New York, London, Frankfurt, Sydney: Datamonitor.
8. Jackson, D. (2003) The pharmaceutical market outlook to 2010: Essential analysis of key drivers of change. Reuters Business Insight, Healthcare. New York, London, Frankfurt, Sydney: Datamonitor.
9. PhRMA (Pharmaceutical Research and Manufacturers of America). (2008) Pharmaceutical Industry Profile 2008. Washington DC: PhRMA.
10. Burrill & Co. (2007) Biotech 2007 Life Sciences: A Global Transformation. San Francisco: Burrill Life Sciences Media Group.
11. Ernst & Young. (2007) Beyond Borders: Global Biotechnology Report. EYGM Limited. www.ey.com, accessed 15 May 2007.
12. Roth, G. (2007) www.contractpharma.com, accessed 23 March 2008.
13. Pisano, G. (2006) Can science be a business? Harvard Business Review 10: 1-12.
14. UBS Securities LLC. (2007) Global pharmaceuticals - Outlook 2008. UBS Investment Research. Zurich: Basel, USB Securities LLC.
15. Cowen & Company. (2008) Pharmaceuticals: Industry Overview, Generic Industry Overview and Patent Case Reviews. New York, Boston, San Francisco, Chicago, Cleveland, London, Geneva: Cowen & Company.
16. Credit Suisse. (2008) Pfizer, Wyeth, Amgen. Equity Research, Major Pharmaceuticals. Zurich: Credit Suisse.
17. Martinez, B. and Goldstein, J. (2007) Big Pharma faces grim prognosis. Wall Street Journal: A1. 6 December.
18. The market for Generic Biologics: Kalorama Information (2004) The Market for Generic Biologics: Issues, Trends and Market Potential. Rockville, MD; New York: Kalorama Information, 1 June.
19. Tufts (The Tufts Center for the Study of Drug Development). (2007) Structuring Clinical Organization to Improve R & D Productivity, accessed 2 April 2007.
20. Kola, I. and Lands, J. (2004) Can the pharmaceutical industry reduce attrition rates? Nature Review Drug Discovery 3: 711-715.
21. CNBC. (2006) Pfizer CEO Plans Acquisitions After Failure of Cholesterol Drug, accessed 16 April 2008.
22. Roner, L. (2005) Forging strategic alliances with biotech partners. Eyeforpharma Briefing.
23. Ahn, M., Vitale, F. and Tong, V. (2005) Biopharmaceutical alliances: It's all academic. Biopharmaceutical International: 24-26.
24. Dolan, A. (2005) Drug alliance alchemy, www.forbes.com, accessed 19 June 2007.
25. Ahn, M. and Meeks, M. (2007) Building a Conducive environment for life science based entrepreneurship and industry clusters. Journal of Commercial Biotechnology 14: 20-30.
26. Porter, M. (1990) Competitive Advantage of Nations. New York: Free Press.
27. Porter, M. (1998) Clusters and the new economics of competition. Harvard Business Review 76: 78-90.
28. Porter, M. (2000) Location, competition, and economic development: Local clusters in a global economy. Economic Development Quarterly 14 (1): 15-35.
29. Marshall, A. (1890) Principles of Economics. London: Macmillan.
30. Schumpeter, J. (1942) Capitalism, Socialism and Democracy. New York: Harper & Row.
31. Solow, R. (1956) A contribution to the theory of economic growth. Quarterly Journal of Economics 70: 65-94.
32. Solow, R. (1957) Technical change and the aggregate production function. Review of Economics and Statistics 39: 312-320.
33. Romer, P. (1994) The origins of endogenous growth. Journal of Economic Perspectives 8 (1): 3-32.
34. Nelson, R. and Romer, P. (1996) Science, economic growth and public policy. In: B. Smith and C. Barfield (eds.) Technology, R & D, and the Economy. Washigton DC: Brookings Institution and American Enterprises Institute, 49-74.
35. Saxenian, S. (1994) Regional Advantage: Culture and Competition in Silicon Valley and Route 128. Boston, MA: Harvard University Press.
36. Audretsch, D. B. (2001) The role of small firms in United States biotechnology clusters. Small Business Economics 17: 3-15.
37. Fujita, M. and Thisse, J. (2002) The Economics of Agglomeration: Cities, Industrial Location and Regional Growth. Cambridge: Cambridge University Press.
38. Rosenthal, S. and Strange, W. C. (2004) Evidence on the nature and source of agglomeration economies, In: J.V. Henderson and J.F. Thisse (eds.) Handbook of Regional and Urban Economics. New York: Elsevier, pp. 2119-2171.
39. Zucker, L. G., Darby, M. R. and Armstrong, J. (1998) Geographically localized knowledge spillovers or markets? Economic Inquiry 36: 65-86.
40. Almeida, P. and Kogut, B. (1999) Localization of knowledge and the mobility of engineers in regional networks. Management Science 4597: 905-917.
41. Desrochers, P. (2001) Geographical proximity and the transmission of tacit knowledge. The Review of Austrian Economics 14 (1): 25-46.
42. Pinch, S., Henry, N., Jenkins, M. and Tallman, S. (2003) From 'industrial districts' to 'knowledge clusters': A model of knowledge dissemination and competitive advantage in industrial agglomerations. Journal of Economic Geography 3 (4): 373-388.
43. Sainsbury, L. (1999) Biotechnology cluster, www.dti.gov.uk, accessed 14 November 2007.
44. Scott, A. J. (1988) Metropolis: From the Division of Labor to Urban Form. Berkeley, CA: University of California Press.
45. Munnich, L. (2004) Knowledge Clusters as a Means of Promoting Regional Economic Development. Minnesota: Humphrey Institute of Public Affairs, University of Minnesota.
46. Rabellotti, R. (1995) Is there an 'industrial district model? Footwear districts in Italy and Mexico compared'. World Development 23 (1): 29-42.
47. Phlippen, S. and van der Knapp, B. (2007) When Clusters Become Networks. Department of Applied Economics, Erasmum University Rotterdam. Tinbergen Institute Discussion Paper.
48. DeVol, R. and Bedroussian, A. (2006) Mind to market: A global analysis of university biotechnology transfer and commercialization. Santa Monica, CA: Milken Institute.
49. Plsek, P. and Wilson, T. (2001) Complexity, leadership, and management in healthcare organisations. British Medical Journal 323: 746-749.
50. Hine, D. and Kapeleris, J. (2006) Innovation and Entrepreneurship in Biotechnology, An International Perspective: Concepts, Theories, and Cases. Northampton, MA: EE Publishing.
51. Battelle. (2007) Growing the Nation's Bioscience Sector: A Regional Perspective, accessed 5 May 2007.
52. Kim, J. W. and Higgins, M. C. (2007) Where do Alliances come from? The effects of upper echelons on alliance formation. Research Policy 36 (4): 499-514.
53. Baum, J. A. C. and Silverman, B. S. (2004) Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance in biotechnology startups. Journal of Business Venturing 19 (3): 411-436.
54. Boehm, T. and Schuehsler, H. (2003) Where do biotechnology venture capitalists go from here? www.biotechclub.org, accessed 3 October 2007.
55. Fair, B. (2007) Building a bioscience cluster. Genetic Engineering News 27 (4): 2.
56. Feldman, M. (2003) The locational dynamics of the US biotech industry: Knowledge externalities and the anchor hypothesis. Industry & Innovation 10 (3): 311-328.
57. Munroe, T., Craft, G. and Hutton, D. (2002) A Critical Analysis of the Local Biotechnology Industry Cluster - Counties of Alameda, Contra Costa, & Solano in California. Research Monograph prepared for the Consortium of Bay Area Organizations, May 2002, www.baybio.org, accessed 14 November 2007.
58. Prevezer, M. (1997) The dynamics of industrial clustering in biotechnology. Small Business Economics 9: 255-271.
59. Ross, J. (2004) Biotechnology growth takes time, www.marshall.edu, accessed 14 November 2007.
60. Zeller, C. (2001) Clustering biotech: A recipe for success? Spatial patterns of growth of biotechnology in Munich, Rhineland, and Hamburg. Small Business Economics 17: 123-141.
61. Ahn, M., Meeks, M., Ross, C., Bednarek, R. and Dalziel, S. (2008) Making Biotechnology Work for New Zealand. NZBIO-GW Research Series.
62. Ahn, M., Meeks, M. and Davenport, S. (2008) Death of distance?: Biotechnology Agglomeration Patterns, Alliance Proximity, and Firm Performance. Academy of Management Conference, Anaheim, California.
63. George, V. and Zaheer, A. (2006) Geographic signatures: Firm proximities and performance. Academy of Management Best Conference Paper 2006, BPS: F1-6.
64. Lehman Brothers, Inc. (2007) Lehman Brothers global pharmaceuticals. Key Metrics, Equity Research, www.lehman.com, accessed 24 October 2007.
65. Yin, R. K. (1984) Case Study Research: Design and Methods. California: Sage Publications.
66. Eisenhardt, K. M. and Graebner, M. E. (2007) Theory building from cases: Opportunities and challenges. Academy of Management Journal 50 (1): 25-32.
67. Hoang, H. and Antoncic, B. (2003) Network-based research in entrepreneurship: A critical review. Journal of Business Venturing 18 (2): 165-187.
68. Pitt, L., van der Merwe, R., Berthon, P., Salehi-Sangari, E. and Barnes, B. (2006) Swedish BioTech SMEs: The veiled values in online networks. Technovation 26 (5-6): 553-560.
69. Hildreth, M. (2006) Beyond Borders: The Global Biotechnology Report - Strength and Stability: The American Perspective. EYGM Limited. www.ey.com, accessed 15 May 2007.
70. Sing, J. (2008) Distributed R & D: Cross regional knowledge integration and quality of innovation output. Research Policy 37 (1): 77-96.
71. Calero, C., Van Leeuwen, T. N. and Tijssen, R. J. W. (2007) Research collaboration within the bio-pharmaceutical industry: Network analyses of co-publications within and between. Scientometrics 11 (1): 87-99.
72. Pisano, G. P. and Verganti, R. (2008) Which kind of collaboration is right for you? Harvard Business Review 86 (December): 78-86.
73. Nambisan, S. and Sawhney, M. (2007) A buyer's guide to the innovation bazaar. Harvard Business Review 85 (June): 109-118.
74. Sermon, D., Gove, S. and Hitt, M. (2008) Resource management in dyadic competitive rivalry: The effects of resource bundling and deployment. Academy of Management Journal 51: 919-935.
75. Bachi, R. (1999) New Methods of Geostatistical Analysis and Graphical Presentation. New York: Kluwer.
76. Stough, R., Kulkarni, R. and Paelinck, J. (2001) Spatial-structural relations among technology industrial clusters: A comparative analysis of metropolitan regions in the US. 41st Congress of the European Regional Science Association; 29 August - 1 September, Zagreb, Croatia.
77. North, D. (1990) Institutions, Institutional Change and Economic Development. Cambridge: Cambridge University Press.
78. Peng, M. W. (2006) Global Strategy. Mason, OH: Thomson South-Western.